stockrow
Friday 6 November 2026
Export EHC’s income statement to Excel — free account
Encompass Health Corporation
EHC Healthcare Medical Care Facilities
Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024.
- Revenue
- +8.93%
- EPS
- +20.6%
- Free cash flow
- +52.3%
- Total debt
- +6.83%
Quarter to September 2026, against a year earlier
138.07
3.20
−2.27%
Follow EHC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
18.84% | 19.68% | 19.30% | 19.43% | |
Piotroski F-Score |
7 | 6 | 7 | 7 | |
| 8.31% | 8.73% | 8.72% | 8.93% | ||
ROIC |
11.74% | 11.89% | 11.79% | 12.06% | |
Return on Tangible Assets |
13.57% | 13.94% | 13.77% | 14.12% | |
Average Days of Receivables |
38.08 | 40.67 | 40.42 | 41.00 | |
Free Cash Flow per Share |
4.37 | 4.68 | 4.18 | 4.65 | |
Free Cash Flow |
439.20 | 464.40 | 413.40 | 457.20 | |
Capital Expenditures |
(736.40) | (735.70) | (799.10) | (846.50) | |
| Other line items | |||||
Cash ROIC |
7.56% | 7.68% | 6.70% | 7.37% | |
Accounts Receivable Turnover |
9.75 | 9.34 | 9.55 | 9.58 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.20) | (0.21) | (0.20) | (0.21) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
60.76% | 60.50% | 60.09% | 59.78% | |
Share Based Compensation of Revenue |
0.95% | 0.96% | 0.93% | 0.93% | |
Interest Coverage |
8.55 | 8.83 | 8.87 | 9.12 | |
Operating CF/Net income |
2.08 | 1.97 | 1.95 | 2.02 | |
Depreciation/Fixed assets |
0.08 | 0.08 | 0.08 | 0.08 | |
Capex/Depreciation |
(2.18) | (2.13) | (2.24) | (2.29) | |
Revenue per Share |
59.06 | 61.15 | 62.81 | 64.48 | |
Operating CF per Share |
11.70 | 12.10 | 12.27 | 13.26 | |
Capex per Share |
(7.33) | (7.42) | (8.09) | (8.61) | |
Capex to Sales |
0.12 | 0.12 | 0.13 | 0.13 |
Columns are period end dates · fundamentals updated 5 Nov 2026